FindTrial
Sign In

Comparison of a Rapid Pneumonia Diagnostic Test with Standard Laboratory Culture in ICU Patients and Its Impact on Antibiotic Treatment.

COMPARATIVE ASSESSMENT OF BIOFIRE PNEUMONIA PANEL AND STANDARD CULTURE IN CRITICALLY ILL PNEUMONIA CASES AND ITS IMPACT ON ANTIMICROBIAL STEWARDSHIP - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107709
Enrollment
70
Registered
2026-04-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: Nil: Nil

Sponsors

MOHAMMED ZAHEER PASHA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who give valid informed consent. Patients diagnosed with pneumonia.

Exclusion criteria

Exclusion criteria: Patients not giving consent. Low quality sputum sample.

Design outcomes

Primary

MeasureTime frame
1.To assess the diagnostic performance of BioFire Pneumonia Panel (BFPP) in comparison with standard-of-care (SOC) culture for rapidly detecting respiratory pathogens and genetic markers among patients with pneumonia.Timepoint: AFTER THE CULTURE REPORTS COMES. USUALLY 3 DAYS—

Secondary

MeasureTime frame
2. To evaluate the performance of BFPP in detecting antimicrobial susceptibility genes compared with culture based methods & its impact on antimicrobial stewardship.Timepoint: AT THE TIME OF DISCHARGE. VARIES FROM PATIENT TO PATIENT.—

Countries

India

Contacts

Public ContactMOHAMMED ZAHEER PASHA

APOLLO BGS HOSPITAL MYSORE

drgirish1703@gmail.com8884214484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026